Genpact Limited Reports Director and Officer Changes

Ticker: G · Form: 8-K · Filed: Sep 30, 2025 · CIK: 1398659

Sentiment: neutral

Topics: leadership-change, governance

TL;DR

Genpact's board and execs are changing up, effective Sept 29.

AI Summary

Genpact Limited filed an 8-K on September 30, 2025, reporting changes effective September 29, 2025. The filing pertains to the departure of directors, election of directors, appointment of officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved and the nature of these changes are outlined within the report.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus, impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future strategy and execution.

Key Players & Entities

FAQ

What specific changes were made regarding directors and officers?

The 8-K filing indicates changes related to the departure of directors, election of directors, and appointment of certain officers, as well as compensatory arrangements for officers.

When were these changes effective?

The changes reported in this 8-K were effective as of September 29, 2025.

What is the primary purpose of this 8-K filing?

The primary purpose is to report current information about significant corporate events, specifically changes in the company's board of directors and executive officers.

Where is Genpact Limited incorporated?

Genpact Limited is incorporated in Bermuda.

What is the principal executive office address for Genpact Limited?

The principal executive office is located at Canon's Court, 22 Victoria Street, Hamilton HM 12, Bermuda.

Filing Stats: 636 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2025-09-30 16:23:12

Key Financial Figures

Filing Documents

From the Filing

g-20250929 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 29, 2025 GENPACT LIMITED (Exact name of registrant as specified in its charter) Bermuda 001-33626 98-0533350 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) Canon's Court, 22 Victoria Street Hamilton HM 12 , Bermuda (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 441 ) 298-3300 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common shares, par value $0.01 per share G New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Genpact Limited (the "Company") has appointed Anthony Radesca as its Senior Vice President and Chief Accounting Officer, effective September 29, 2025. Mr. Radesca, age 56, served as Senior Vice President and Chief Accounting Officer of NCR Voyix Corporation from May 2024 to September 2025. Prior to that, he served as Senior Vice President, Chief Accounting Officer of EVO Payments, Inc. from February 2019 to March 2023. Mr. Radesca previously served as Senior Vice President, Chief Accounting Officer of CA Technologies, Inc. from June 2016 to February 2019, and as Vice President of Accounting of CA Technologies from June 2008 to June 2016. Mr. Radesca holds a B.B.A. in Public Accounting from Hofstra University, a J.D. from St. John's University School of Law and is a Certified Public Accountant. In connection with his appointment as Senior Vice President and Chief Accounting Officer, Mr. Radesca will be entitled to receive base salary, annual bonus opportunities, and equity awards consistent with his role and seniority. He will also be eligible to participate in certain Company-sponsored benefits, such as health insurance plans and disability and life insurance plans. There are no arrangements or understandings between Mr. Radesca and any other person pursuant to which he was appointed as Senior Vice President and Chief Accounting Officer. There are no family relationships between Mr. Radesca and any director or executive officer of the Company, and there have been no transactions between Mr. Radesca and the Company in the last fiscal year, and none are currently proposed, that would require disclosure under Item 404(a) of Regulation S-K. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENPACT LIMITED Date: September 30, 2025 By: /s/ Heather D. White Name: Heather D. White Title: Senior Vice President, Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing